Oireachtas Joint and Select Committees

Thursday, 8 November 2018

Public Accounts Committee

Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation

9:00 am

Mr. Damien McCallion:

No, it is a significant challenge. The only laboratory working on that at the moment is the Coombe. We are working with that laboratory in trying to develop its capacity but we will have a combination of private and public. At the moment, the Coombe only does about 9%. One of the issues being identified is that cytologists, the professionals who do the screening, are starting to diminish as a profession because as we move to HPV testing we need fewer of those professionals. Every country in the world is struggling with this now. We have spoken to our colleagues in Northern Ireland, Australia, New Zealand and England. The team even went to the Netherlands to look at its HPV testing implementation. There are real challenges for people in the older system because if we are going to need 80% less of that resource down the line, professionally people are seeking to move. It would take some time to grow the capacity here in Ireland but it can be done. That is one of our objectives but we need to be careful in the sense that we will still need the private sector to support us as well. That is particularly the case with the increased demand in the programme. Our priority is to make sure we sustain the programme, and try to achieve capacity in Ireland alongside of it.

Comments

No comments

Log in or join to post a public comment.